Thomas Andrew Crockett

Insider Reports History

Entity
Individual
Location
Building 227, Tetricus Science Park, Porton Down, Salisbury, Wiltshire, United Kingdom
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Thomas Andrew Crockett:

Stock Role Class Num Shares Value Price $ Report Date Ownership
KalVista Pharmaceuticals, Inc. CEO, Director Common Stock 211K $2.98M $14.11 Feb 20, 2024 Direct
KalVista Pharmaceuticals, Inc. CEO, Director Performance Stock Units 62.5K $938K $15.01 Feb 17, 2024 Direct
KalVista Pharmaceuticals, Inc. CEO, Director Restricted Stock Unit 48.6K $730K $15.01 Feb 17, 2024 Direct
KalVista Pharmaceuticals, Inc. CEO, Director Performance Stock Unit 0 $8.23 Nov 17, 2023 Direct

Insider Reports Filed by Thomas Andrew Crockett

Symbol Company Period Transactions Value $ Form Type Date Filed Role
KALV KalVista Pharmaceuticals, Inc. Feb 17, 2024 6 -$351K 4 Feb 21, 2024 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Feb 14, 2024 1 -$876K 4 Feb 16, 2024 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Feb 11, 2024 2 $0 4 Feb 13, 2024 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Feb 1, 2024 2 -$162K 4 Feb 5, 2024 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Dec 27, 2023 1 -$360K 4 Dec 28, 2023 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Nov 17, 2023 5 -$122K 4 Nov 21, 2023 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Oct 30, 2023 1 $0 4 Nov 1, 2023 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Aug 17, 2023 5 -$160K 4 Aug 21, 2023 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Feb 17, 2023 1 $0 4/A May 22, 2023 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Jan 11, 2023 5 -$57.1K 4 May 19, 2023 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Nov 17, 2022 3 -$9.71K 4 Nov 21, 2022 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Sep 2, 2022 2 -$22.5K 4 Sep 7, 2022 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Aug 17, 2022 3 -$26.9K 4 Aug 19, 2022 CEO, Director
KALV KalVista Pharmaceuticals, Inc. May 17, 2022 2 $0 4 May 19, 2022 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Mar 9, 2022 1 -$171K 4 Mar 11, 2022 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Oct 1, 2021 1 -$172K 4 Oct 4, 2021 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Jul 1, 2021 2 -$241K 4 Jul 2, 2021 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Jun 17, 2021 1 -$32.1K 4 Jun 22, 2021 CEO, Director
KALV KalVista Pharmaceuticals, Inc. Jun 9, 2021 1 -$268K 4 Jun 11, 2021 CEO, Director
KALV KalVista Pharmaceuticals, Inc. May 26, 2021 2 $0 4 May 28, 2021 CEO, Director